Major global trends driving biotech investment in 2021
"Antisense Therapeutics Limited (ASX: ANP and FWB: AWY) Antisense technology represents an important breakthrough in disease treatment. With access to Ionis Pharmaceuticals’ proprietary drug discovery process, Antisense Therapeutics Limited can move quickly from drug discovery into developing therapies. Once a therapeutic application and corresponding gene target has been identified, an antisense lead inhibitor compound can be rationally designed within hours suitable for use in research and clinical trials. This compares with traditional drug discovery approaches which can take years to produce such a lead compound. Antisense drug development also benefits from uniform methods of manufacture, formulation, and delivery of antisense compounds.Antisense is an innovative platform for drug discovery. Biotech platform technologies combine all the elements that are necessary to rapidly and efficiently create a stream of new products."
https://www.greenleiter.com/post/major-global-trends-driving-biotech-investment-in-2021?postId=6048c822ba40b1002b989db9
- Forums
- ASX - By Stock
- PER
- Sarepta gene therapy study missed key target in Duchennes
Sarepta gene therapy study missed key target in Duchennes, page-334
-
- There are more pages in this discussion • 80 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
8.5¢ |
Change
-0.002(2.30%) |
Mkt cap ! $76.63M |
Open | High | Low | Value | Volume |
8.7¢ | 8.7¢ | 8.5¢ | $12.66K | 146.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 197135 | 8.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.7¢ | 329525 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 197135 | 0.085 |
3 | 457608 | 0.084 |
3 | 212500 | 0.083 |
1 | 21000 | 0.081 |
2 | 106250 | 0.080 |
Price($) | Vol. | No. |
---|---|---|
0.087 | 329525 | 1 |
0.088 | 457142 | 2 |
0.089 | 135000 | 2 |
0.090 | 294374 | 4 |
0.092 | 550000 | 2 |
Last trade - 10.14am 02/09/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online